Texas lawmakers are preparing for a renewed debate over cannabis and emerging psychedelic therapies, with top Republican leaders in both chambers directing committees to study the issues ahead of the state’s next legislative session in 2027.
Lt. Gov. Dan Patrick, who presides over the Senate, has instructed the Senate Health and Human Services Committee to examine the “societal impacts” of THC consumption. The directive follows his unsuccessful push last session to ban hemp-derived THC products—a proposal that cleared the legislature but was ultimately vetoed by Gov. Greg Abbott.
Patrick’s interim charge focuses heavily on public health concerns, asking lawmakers to analyze whether THC use is contributing to higher health care costs, increased mental health emergency detentions and a greater risk of THC-induced psychosis. The committee is also tasked with recommending ways to reduce associated health care and criminal justice expenses, signaling that restrictions on THC products could again be a priority when lawmakers reconvene.
Meanwhile, House Speaker Dustin Burrows is steering attention toward a different, but related, frontier: psychedelic-assisted therapy. He has directed the House Public Health Committee to monitor the rollout of a newly enacted law supporting clinical trials of ibogaine, a psychedelic compound being studied as a potential treatment for substance use disorders and other mental health conditions.
The legislation, signed by Abbott, establishes a state-backed consortium to pursue U.S. Food and Drug Administration approval for ibogaine as a prescription medication. It also positions Texas to benefit financially, granting the state a stake in any intellectual property developed through the trials, with a portion of proceeds earmarked for veterans programs.
These interim studies come amid significant regulatory changes. Earlier this month, the Texas Department of State Health Services adopted new rules requiring hemp products to be tested for “total THC,” effectively banning most smokable hemp flower products by including THCA in potency calculations.
Public opinion on cannabis policy appears mixed but trending toward reform. Recent polling shows more Texans disapprove than approve of how state leaders have handled marijuana issues, while separate surveys indicate a growing preference for less restrictive laws. Still, hemp regulation ranked low among voter priorities during recent legislative debates.
Together, the studies ordered by Patrick and Burrows set the stage for a wide-ranging policy clash in 2027, as Texas weighs stricter THC controls alongside potential leadership in psychedelic medicine research.
Read the whole article from Marijuanamoment here.
The post Texas Senate Approves Cannabis & Psychedelic Research appeared first on Weed Deep Dive.
